Envestnet Asset Management’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,143
Closed -$6.28K 4112
2023
Q1
$6.28K Buy
+1,143
New +$7.76K ﹤0.01% 3951
2022
Q4
Sell
-756
Closed -$4K 4101
2022
Q3
$4K Buy
756
+1
+0.1% +$11 ﹤0.01% 3893
2022
Q2
$7K Sell
755
-5
-0.7% -$51 ﹤0.01% 3907
2022
Q1
$12K Sell
760
-147
-16% -$2.55K ﹤0.01% 3919
2021
Q4
$24K Buy
907
+230
+34% +$8.72K ﹤0.01% 3845
2021
Q3
$33K Buy
+677
New +$41.8K ﹤0.01% 3651

Other funds holding AWH

Envestnet Asset Management's AWH Position: Q2 2023 in Review

Envestnet Asset Management sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q2 2023, closing a stake of 1,143 shares — an estimated $6.28K sold.

Envestnet Asset Management first reported a position in AWH in Q3 2021 and held it in 6 quarters. The position peaked at $33K in Q3 2021. 22 funds tracked by Wall St. Rank hold AWH as of Q2 2023.

  • Envestnet Asset Management reported no remaining Aspira Women's Health Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Envestnet Asset Management sold 1,143 Aspira Women's Health Inc. Common Stock shares in Q2 2023, an estimated $6.28K.
  • Envestnet Asset Management first reported a position in Aspira Women's Health Inc. Common Stock in Q3 2021 and held it in 6 quarters.
  • Envestnet Asset Management's Aspira Women's Health Inc. Common Stock position peaked at $33K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q2 2023.

Based on Envestnet Asset Management's 13F filing for Q2 2023, filed 4 Aug 2023.